| Date | Title | Description |
| 03.11.2025 | First clinical trial of pig kidney transplants gets underway | By LAURAN NEERGAARD, AP Medical Writer
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives. Related Articles
Federal judge won’t block Colorado prescription ... |
| 08.09.2025 | Another New Hampshire man gets a pig kidney as transplant trials are poised to start | By LAURAN NEERGAARD
WASHINGTON (AP) — A self-described science nerd is the latest American to get an experimental pig kidney transplant, at a crucial point in the quest to prove if animals organs really might save human lives.
The 54-year-o... |
| 13.08.2025 | 3D Systems reports “improved profitability” in Q2 despite 16% revenue drop | Discover more at Additive Manufacturing Advantage: Energy, on September 17. Register for free!
US-based 3D printer manufacturer 3D Systems (NYSE: DDD) has released its financial results for the second quarter of 2025 (Q2 2025).
Revenue for ... |
| 30.06.2025 | 3D Systems and TISSIUM Receive FDA Approval for First-of-its-Kind Peripheral Nerve Repair Device | U.S.-based 3D printer manufacturer 3D Systems, in partnership with French MedTech firm TISSIUM, has secured FDA approval for a bioabsorbable, 3D printed device designed to treat peripheral nerve damage. This approval validates the polymer’s... |
| 26.06.2025 | Asteroid Day: A Cosmic Call to Action | Asteroids are not just rocks in space. They are messengers from the dawn of our solar system. As humanity looks to the stars, we must also look to the threats and opportunities these celestial bodies present. June 30th marks Asteroid Day, a... |
| 20.06.2025 | California Live Spotlights Innovation and Real Estate with Dr. Nuno Martins | Share
Share
Share
Share
Email
California Live Podcast with Victor Migalchan takes listeners on an expansive journey through real estate, innovation, and global transformation with featured guest Dr. Nuno Martins. A seasoned entrepreneur, in... |
| 27.03.2025 | 3D Systems 2024 financial results report stronger year end after revenue dip | US-based 3D printer manufacturer 3D Systems (NYSE: DDD) has released its financial results for full-year 2024 (FY 2024), and fourth quarter of 2024 (Q4 2024).
FY 2024 revenue came in at $440.1 million, down 9.8% from $488.1 million in FY 20... |
| 08.11.2024 | BETA Technologies: Electric Aerospace Company Raises Over $300 Million | BETA Technologies—an electric aerospace company based in Vermont—announced it has raised $318 million in Series C equity capital. QIA led the raise, and several of BETA’s largest investors, including Fidelity Management & Research Compa... |
| 04.11.2024 | BETA Technologies Raises More Than $300M in Equity Funding | BETA Technologies, a South Burlington, VT-based electric aviation company, raised more than $300M in Equity funding.
The round was led by QIA, with participation from Fidelity Management & Research Company, TPG Rise Climate, and United ... |
| 01.10.2024 | Frontier Bio’s lab-grown lung tissue – a new way for future transplants and respiratory treatments | Biotechnology research company Frontier Bio has reported progress in developing lab-grown lung tissue, achieved by integrating bioprinting with the natural self-organizing properties of stem cells.
Nominations for the 2024 3D Printing Indus... |
| 23.05.2024 | Maryland Organizations Invest in Growth, Education, and Community | - Courtesy of Maryland Marketing Partnership
The Maryland Marketing Partnership, which helps drive Maryland's branding and marketing efforts to attract businesses, create jobs, and grow the state's economy, today shared a summary of the lat... |
| 22.05.2023 | Driving Economic Progress: Maryland's Business Community Celebrates Phenomenal Growth | Construction Progress of the Aspen, a 388-unit luxury apartment complex, part of St. John Properties’ Melford Town Center mixed-use community in Bowie, MD. With each passing day, we witness a remarkable surge as our state's entrepreneurs an... |
| 06.03.2023 | MIT researchers 3D print patient-specific robotic heart | Researchers at the Massachusetts Institute of Technology (MIT) have developed a method for 3D printing a flexible and soft replica of a patient’s heart.
The team can then direct the activity of the replica to imitate the patient’s blood-pum... |
| 05.01.2023 | CollPlant’s 3D bioprinted breast implants achieve “promising results” in animal testing | Regenerative medicine specialist CollPlant has announced that its proprietary 3D bioprinted breast implants have successfully passed animal testing.
Bioprinted from ‘rhCollagen,’ a plant-based alternative to human collagen, CollPlant’s impl... |
| 09.09.2022 | 3D Systems spins off new 3D bioprinting firm with goal of accelerating drug discovery R&D | US 3D printer manufacturer 3D Systems has announced the formation of a new 3D bioprinting subsidiary.
Named Systemic Bio, the company is set to utilize the technologies developed as part of its parent firm’s Print to Perfusion program as we... |
| 11.08.2022 | Prellis Biologics hires new CEO, raises $35M towards 3D bioprinted lymph node R&D | Prellis Biologics has raised $35 million and appointed a new CEO as it seeks to advance the development of its proprietary 3D bioprinted lymph node.
Raised via a Series C funding round led by Celesta Capital and Avidity Partners, and backed... |
| 10.08.2022 | 3D Systems buys dp polar to push ahead with expansion, revenue falls in “challenging” Q2 | US 3D printer manufacturer 3D Systems (DDD) has announced that its revenue fell 13.9% in Q2 2022.
As revealed in its Q2 2022 financials, 3D Systems brought in $140.0 million in revenue, $22.6 million less than it earned in Q2 2021, and an 1... |
| 07.06.2022 | United Therapeutics and 3D Systems shoot for 3D printed lung scaffold trials within five years | Biotechnology firm United Therapeutics has showcased what it claims to be the “world’s most complex 3D printed object” in partnership with 3D printer manufacturer 3D Systems at the recent LIFE ITSELF conference in San Diego.
The partners ha... |
| 31.03.2022 | CollPlant to trial 3D bioprinted breast implants in breakthrough animal study | Regenerative medicine specialist CollPlant (NASDAQ: CLGN) has revealed that the 3D bioprinted breast tissues it’s developing are set to enter animal trials in the very near future.
Alongside the release of its FY 2021 results, which show th... |
| 23.02.2022 | CollPlant partners with CELLINK in bid to address $2.8BN regenerative breast implant market | Regenerative medicine specialist CollPlant has partnered with BICO firm CELLINK in an effort to ramp up its production of 3D bioprinted breast implants.
Currently undergoing preclinical trials, CollPlant’s bioprinted grafts are designed to ... |
| 09.02.2022 | Trestle Biotherapeutics licenses kidney implant 3D bioprinting technology from Harvard | 3D Printing Industry is currently seeking feedback on material usage across the sector. Have your say in the Spotlight on Resin 3D Printing Survey now.
San Diego-based bioengineering start-up Trestle Biotherapeutics has gained a license for... |
| 09.11.2021 | 3D Systems revenue rises 15% ahead of anticipated “high-margin growth” acquisitions | U.S. 3D printer manufacturer 3D Systems (DDD) has revealed that its revenue rose by 15% during Q3 2021, despite the substantial divestiture drive it has undergone over the last 12 months.
As revealed in the firm’s financials, it generated r... |
| 03.11.2021 | United Therapeutics Corporation Reports Third Quarter 2021 Financial Results | SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Nov. 3, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation with a purpose to provide a brighter future for patients, today announced its fin... |
| 03.11.2021 | United Therapeutics Corporation Reports Third Quarter 2021 Financial Results - Form 8-K | United Therapeutics Corporation Reports
Third Quarter 2021 Financial Results
SILVER SPRING, MD. and RESEARCH TRIANGLE PARK, N.C., November 3, 2021: United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation with a purpose ... |
| 28.10.2021 | 3D Systems to expand bioprinting program after buying Volumetric Biotechnologies for $400M | U.S. 3D printer manufacturer 3D Systems has unveiled plans to expand on its bioprinting program after acquiring Volumetric Biotechnologies for $400 million.
Bought for an initial $45 million, with a further $355 million set to be paid upon ... |
| 27.10.2021 | 3D Systems and United Therapeutics Announce Expansion of Bioprinting Program | Amendment expands program from a singular focus on the bioprinting of human lung scaffolds to the development and demonstration of two additional human organs
Amendment will become effective upon closing of 3D Systems’ acquisition of Volume... |
| 21.10.2021 | Exclusive: Athira CEO Leen Kawas resigns after investigation finds she manipulated data | Six years ago, Boehringer Ingelheim announced that a new manufacturing plant focused on large-scale cell culture technology would be erected in Vienna, marking the largest investment in the company’s history. Last week, the site became oper... |
| 21.10.2021 | Exclusive: Athira CEO Leen Kawas resigns after investigation finds she manipulated data | Years before the pandemic, Moderna’s CEO Stéphane Bancel had thoughts of using mRNA to fight neglected tropical diseases.
Now, while under the magnifying glass of the US government and public health organizations alike, his company will try... |
| 21.10.2021 | Exclusive: Athira CEO Leen Kawas resigns after investigation finds she manipulated data | Bayer will invest $460 million into two manufacturing sites to expand its production capabilities for contraceptives to low- and middle-income countries.
Through a deal involving the UN Population Fund and the US Agency for International De... |
| 21.10.2021 | Recall report: Glass found in Merck antibiotic threatens 22,000 vials | A Merck antibiotic has been recalled after reports of the presence of glass particulate matter, the company announced Tuesday.
One lot of Cubicin will be recalled, which includes about 22,000 vials of the 500mg dose of th... |
| 21.10.2021 | Exclusive: Athira CEO Leen Kawas resigns after investigation finds she manipulated data | In 2019, High Purity New England, a biopharma solutions and equipment supplier and distributor based out of Smithfield, Rhode Island, had just 60 employees. Thanks to a push in demand, largely fueled by the pandemic, it hopes it can end the... |
| 21.10.2021 | Novartis expands Covid-19 vaccine manufacturing deal with Pfizer/BioNTech; Exacis links with CCRM for NK cell therapies | BioNTech has signed an agreement with Novartis to expand fill-finish support for the company’s Covid-19 vaccine — made in collaboration with Pfizer in Slovenia.
The Ljubljana, Slovenia sterile manufacturing site will ... |
| 21.10.2021 | FDA rejects United's potential PAH drug due to a manufacturing issue | United Therapeutics said Monday that it received a complete response letter for its potential pulmonary arterial hypertension drug Tyvaso DPI, due to an issue with a third-party facility that performs drug substa... |
| 20.10.2021 | Manufacturing woes for Novavax’s Covid jab badly disrupt plans for rollout to the poor — report | Production problems at a Novavax facility in Maryland have led to delays in the Covax vaccine sharing program. Now, a shortage of 1 billion doses is expected, as the supplier tries to navigate producing a shot up to... |
| 14.10.2021 | As flu season emerges, BD completes syringe manufacturing lines with help from US government; Hot off summertime debut on NYSE, construction on Stevanato's midwest site begins... | BD has upped the US government’s access to safety injection devices through the investment of two new syringe and needle manufacturing lines.
The company completed construction of the lines on a sped-up timeline throug... |
| 14.10.2021 | A California biotech steps into the viral vector space with new site build of $75M | As cell and gene therapy gets hotter, a California CDMO has made a play to open an entirely new arm of its operations to fill a void in the market.
Avid Bioservices will move into the cell and gene therapy market, with the... |
| 07.10.2021 | Eli Lilly's recently recalled glucagon kits were produced at troubled Indianapolis site — report | Days after it was revealed that Eli Lilly’s diabetes injection kit had been recalled after a report of a mixup of glucagon substance, Reuters has reported the kits were manufactured in the Indianapolis plant called out i... |
| 07.10.2021 | BioCina completes takeover of Pfizer-owned Australia plant; Cambrex adds space at NC site for small molecules | San Diego CDMO BioCina has finalized the final transition of its takeover of an Australian manufacturing site to boost its mRNA operations.
BioCina completed the acquisition from Pfizer-owned Hospira Adelaide, whic... |
| 07.10.2021 | As continent's vaccination rate sits below 5%, Moderna announces investment in mRNA manufacturing in Africa | After mounting pressure from competitors, Moderna has signed on to invest $500 million in an mRNA manufacturing site in Africa that could make up to 500 million doses a year.
It’s a move into a region that has been largel... |
| 04.10.2021 | Thermo Fisher expands into Switzerland as part of CSL collaboration | Just days after Thermo Fisher Scientific prepped to expand a St. Louis plant, the company announced it’s taking over a new, 1.5 million-square-foot site in Switzerland with plans to add 200 new employees.
The move is a part o... |
| 04.08.2021 | United Therapeutics Corporation : Reports Second Quarter 2021 Financial Results | SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 4, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the quarter ended June 30, 2021. Total revenue in the second quarter ... |
| 04.08.2021 | United Therapeutics : Tyvaso® (treprostinil) Inhalation Solution net revenue growth of 29% year over year; total net revenue growth of 23% year over year Tyvaso DPI™ NDA under review with FDA action e... | Tyvaso® (treprostinil) Inhalation Solution net revenue growth of 29% year over year; total net revenue growth of 23% year over year
Tyvaso DPI™ NDA under review with FDA action expected in October 2021
SILVER SPRING, MD. and RESEARCH TRIANG... |
| 30.06.2021 | United Therapeutics : Announces The Lancet Respiratory Medicine Publication Of Post-Hoc Analysis Of FVC Change From The Tyvaso® INCREASE Study | SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., June 30, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced the publication in The Lancet Respiratory Medicine of a post-hoc analysis of forced vital capa... |
| 16.06.2021 | MANNKIND CORPORATION
MannKind : United Therapeutics Announces FDA Acceptance of Tyvaso DPI™ New Drug Application For Priority Review | SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., June 16, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced that the U.S. Food and Drug Administration (FDA) accepted for priority review the New Drug App... |
| 03.06.2021 | UNITED THERAPEUTICS CORPORATION
United Therapeutics : Announces First Patient Enrolled In Phase 3 TETON Study Of Tyvaso In Patients With Idiopathic Pulmonary Fibrosis | SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., June 3, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that the first patient has enrolled in the phase 3 TETON study, which is expected to evaluate a... |
| 05.05.2021 | UNITED THERAPEUTICS CORPORATION
United Therapeutics : TETON study of Tyvaso in idiopathic pulmonary fibrosis (IPF) expected to enroll its first patients in the second quarter of 2021 | TETON study of Tyvaso in idiopathic pulmonary fibrosis (IPF) expected to enroll its first patients in the second quarter of 2021
Silver Spring, Md. and Research Triangle Park, N.C., May 5, 2021: United Therapeutics Corporation (Nasdaq: UTHR... |
| 05.05.2021 | UNITED THERAPEUTICS CORPORATION
United Therapeutics Corporation : Reports First Quarter 2021 Financial Results | SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., May 5, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the quarter ended March 31, 2021. Total revenue in the first quarter o... |
| 19.04.2021 | UNITED THERAPEUTICS CORPORATION
United Therapeutics : Announces Submission of Tyvaso DPI™ New Drug Application to FDA | SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 19, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced the submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA)... |
| 01.04.2021 | UNITED THERAPEUTICS CORPORATION
United Therapeutics : Announces FDA Approval and Launch of Tyvaso® for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease | SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 1, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced that the U.S. Food and Drug Administration (FDA) has approved Tyvaso® (treprostinil) Inhalatio... |
| 24.02.2021 | United Therapeutics Corporation : Reports Fourth Quarter And Full Year 2020 Financial Results | SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 24, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the fourth quarter and year ended December 31, 2020. Full year net r... |
| 24.02.2021 | UNITED THERAPEUTICS CORPORATION
United Therapeutics Corporation : Reports Fourth Quarter And Full Year 2020 Financial Results | SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 24, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the fourth quarter and year ended December 31, 2020. Full year net r... |
| 14.12.2020 | United Therapeutics Stock Looks Fully Valued At $137 | After a 63% rise since the March 23 levels of this year, at the current price of around $137 per share we believe United Therapeutics stock (NASDAQ: UTHR), a biotechnology company, has reached its near-term potential. UTHR stock has rallied... |
| 17.09.2018 | Here’s a look at Maryland’s publicly-traded biotech companies | When talk turns to Maryland’s biotech bonafides, the ideas and talent being produced by government institutions like NIH, and research-oriented universities with connected health systems such as Johns Hopkins and University of Maryland are ... |
| 15.12.2017 | Медицина будущего: 7 главных трендов | Команда проекта Medical Note составила список интересных бизнесу направлений высокотехнологичной медицины на ближайшие 5 лет.
10 10 комментариев
35 613 просмотров
Сервис для поддержания здоровья всей семьи Medical Note.
Последние несколько ... |
| 21.07.2017 | Dayton Misfeldt Op-Ed: Orphan Diseases Or Population Health? Policy Choices Drive Venture Capital Investments | Article in Health Affairs
The US exhibits a remarkable pipeline of biopharmaceutical innovation, with 170 new drugs and biologics launched into the market between 2011 and 2015 and another 22 drugs approved in 2016. A striking feature of t... |
| 24.03.2015 | SXSW Interactive 2015: Our future selves, a maturing health tech industry and why failing is productive | By Judy Wang
In 2012, when I attended the South by Southwest (SXSW) Interactive conference for the first time, health tech was still an emerging field. It was the first year the world’s leading conference for emerging technology and digital... |
| 27.05.2011 | Former Nasdaq executive Johnson pleads to insider trading (Morning Read) | Pfizer strategic partnership: Pfizer is the latest large pharmaceutical company to enter a strategic partnership with clinical research organizations. The company has entered into agreements with both Icon and Parexel to be preferred provid... |
| 27.10.2008 | Transoma brings in $5M for heart diagnostics | Transoma, maker of cardiovascular monitoring and diagnostic products, landed $5 million in fourth-round funding from United Therapeutics, Affinity Capital Management, Canaan Partners, Cross Creek Capital and Polaris Venture Partners, report... |
| - | Former Nasdaq executive Johnson pleads to insider trading (Morning Read) | Current medical news and unique business news for anyone who cares about the healthcare industry.
Insider trading: Former Nasdaq Managing Director Donald Johnson has pleaded guilty to one count of securities fraud. Johnson was charged for i... |
